We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NPKI
1701
NPK International
NPKI
$1.15B
| $1.3M | ﹤0.01% |
142,267
+3,100
| +2% | +$28.3K |
|
|
CONE
1702
DELISTED
CyrusOne Inc Common Stock
CONE
| $1.29M | ﹤0.01% |
41,585
+1,800
| +5% | +$53.1K |
|
|
HOS
1703
DELISTED
Hornbeck Offshore Services, Inc.
HOS
| $1.29M | ﹤0.01% |
68,819
+100
| +0.1% | +$2.08K |
|
1704
Comfort Systems
FIX
$59.8B
| $1.29M | ﹤0.01% |
61,435
+2,150
| +4% | +$38.3K |
|
|
BGC
1705
DELISTED
General Cable Corporation
BGC
| $1.28M | ﹤0.01% |
74,509
+520
| +0.7% | +$7.36K |
|
1706
SunCoke Energy
SXC
$800M
| $1.28M | ﹤0.01% |
85,755
+4,700
| +6% | +$80.2K |
|
|
WBK
1707
DELISTED
Westpac Banking Corporation
WBK
| $1.28M | ﹤0.01% |
42,825
+2,233
| +6% | +$64.1K |
|
|
HA
1708
DELISTED
Hawaiian Holdings, Inc.
HA
| $1.28M | ﹤0.01% |
58,086
+6,900
| +13% | +$147K |
|
1709
Emergent Biosolutions
EBS
$259M
| $1.28M | ﹤0.01% |
44,411
-50
| -0.1% | -$1.43K |
|
1710
Royal Bank of Canada
RY
$293B
| $1.27M | ﹤0.01% |
21,060
-100
| -0.5% | -$6.15K |
|
|
RAVN
1711
DELISTED
Raven Industries Inc
RAVN
| $1.27M | ﹤0.01% |
62,049
+11,125
| +22% | +$241K |
|
1712
Interparfums
IPAR
$3.89B
| $1.27M | ﹤0.01% |
38,877
+750
| +2% | +$20.9K |
|
|
PDLI
1713
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.27M | ﹤0.01% |
180,251
+33,075
| +22% | +$240K |
|
|
SGY
1714
DELISTED
Stone Energy
SGY
| $1.27M | ﹤0.01% |
1,520
-27
| -2% | -$23.9K |
|
1715
MannKind Corp
MNKD
$1.32B
| $1.26M | ﹤0.01% |
48,584
+6,881
| +17% | +$207K |
|
|
SSI
1716
DELISTED
Stage Stores Inc
SSI
| $1.26M | ﹤0.01% |
55,076
-455
| -0.8% | -$9.77K |
|
|
BLOX
1717
DELISTED
Infoblox Inc
BLOX
| $1.26M | ﹤0.01% |
52,782
+8,720
| +20% | +$187K |
|
1718
Azenta
AZTA
$1.45B
| $1.25M | ﹤0.01% |
107,904
+3,200
| +3% | +$39.2K |
|
|
CSR
1719
Centerspace
CSR
$949M
| $1.25M | ﹤0.01% |
16,713
+900
| +6% | +$71K |
|
1720
Astronics
ATRO
$3.71B
| $1.25M | ﹤0.01% |
30,973
+5,566
| +22% | +$190K |
|
1721
St. Joe Company
JOE
$3.84B
| $1.24M | ﹤0.01% |
66,865
+8,200
| +14% | +$141K |
|
1722
Renasant Corp
RNST
$3.93B
| $1.23M | ﹤0.01% |
41,051
-675
| -2% | -$19K |
|
|
TBI
1723
Trueblue
TBI
$311M
| $1.23M | ﹤0.01% |
50,662
+4,090
| +9% | +$91.9K |
|
1724
Globalstar
GSAT
$10.7B
| $1.23M | ﹤0.01% |
24,616
+814
| +3% | +$33.6K |
|
1725
Marten Transport
MRTN
$1.24B
| $1.23M | ﹤0.01% |
132,548
+61,793
| +87% | +$546K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.